![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Perlegen Partners With AstraZeneca for Genome Study
Perlegen Partners With AstraZeneca for Genome Study
Perlegen Sciences will conduct a high-density whole genome study for an undisclosed trait of interest with global pharmaceutical company AstraZeneca. This is the second project the Mountain View, Calif. biotech company has formed with AstraZeneca in just over a year. Perlegen will assay human genetic variants (SNPs) in individuals with a specific trait and compare with individuals without the trait.
BioTechConnect (http://www.innovationworld.net/biotechconnect/000565.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct